Do clinical trials prepare to fail by failing to prepare? An examination of MS trials and recommendations for patient-reported outcome measure selection

Authors

Jeremy Hobart, Peninsula Medical School
Tanuja Chitnis, Harvard University
Jiwon Oh, University of Toronto
Laurie Burke, LORA Group, LLC
Miriam King, Novartis
Pamela Vo, Novartis
Jo Vandercappellen, Novartis
Andrew Lloyd, Acaster Lloyd Consulting Ltd

ORCID

• Jeremy Hobart: 0000-0002-2114-7920

DOI Link

10.1016/j.msard.2023.104788

DOI

10.1016/j.msard.2023.104788

Publication Date

2023-01-01

Publication Title

Multiple Sclerosis and Related Disorders

Volume

76

ISSN

2211-0348

Embargo Period

2023-08-16

Recommended Citation

Hobart, J., Chitnis, T., Oh, J., Burke, L., King, M., Vo, P., Vandercappellen, J., & Lloyd, A. (2023) 'Do clinical trials prepare to fail by failing to prepare? An examination of MS trials and recommendations for patient-reported outcome measure selection', Multiple Sclerosis and Related Disorders, 76. Available at: 10.1016/j.msard.2023.104788